Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
115.00    3.50 (3.14%)
Bid:
112.00
Ask:
118.00
Spread: 6.00 (5.357%)
Market Cap: £69.19m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Re Contract

21 Jan 2005 09:11

Intercede Group PLC21 January 2005 Intercede Group plc Intercede's partnership with Gemplus reinforced by significant order Intercede, a leading provider of smart card and identity management software,today announces that it has received an order in excess of £0.5m from Gemplus, aleading provider of smart card solutions, for a major European customer. Since2003, Intercede and Gemplus have developed a strong partnership built aroundIntercede's MyID Smart Card and Identity Management System, as part of Gemplus'smart card-based corporate ID solution, SafesITe. "This success demonstrates that our strategy of delivering Intercede's MyIDtechnology to major customers through channel partners is starting to producesignificant sales revenues. The order reinforces the mutual importance ofGemplus as an Intercede partner and illustrates that our combined solutions havematured into a compelling offering to the market," said Richard Parris, Chairmanand Chief Executive, Intercede Group plc. "Using MyID with Gemplus smart cards,readers and middleware, enables organisations to securely identify andauthenticate individuals in a practical and cost-effective manner. We lookforward to working with Gemplus on other smart card projects for customersaround the World" Gemplus' SafesITe solution incorporates Intercede's MyID to provide auser-friendly method to deploy and manage smart cards for organisations choosingto adopt corporate ID cards with Microsoft PKI credentials. The corporate IDcards can be used to securely access business information and data from theorganisation's PCs, Networks, VPNs and Web resources as well as providingphysical access to offices and buildings. "Our technical partnership with Intercede has quickly grown into what is now afruitful and successful business venture that allows both our companies tobetter engage the corporate ID market," said Olivier Chavrier, Gemplus Directorof Marketing for ID & Security. "This contract well reflects the growinginterest and escalating need for smart card-based identity solutions in theenterprise." About IntercedeIntercede Group plc is a leading developer and supplier of smart card andidentity management software traded on AIM, a market operated by the LondonStock Exchange (IGP LN) (IGP.L). The Group's MyIDTM software manages the secureregistration, issuance and lifecycle of digital identities for a wide range ofuses. This requires the integration of multiple technologies and products frommany different vendors, including smart cards, biometrics, digital certificatesand Open Platform applets.Intercede's customers cover a range of industries and include Athena Smart CardSystems, Barclays Bank, BEWAG, Department of Transport Ireland, Fujitsu, LloydsTSB, the UK National Health Service (NHS), the Metropolitan Police, PinkRoccade,Royal Bank of Scotland, Ubizen and various US and UK Government agencies anddepartments. For more information, visit Intercede's home page at www.intercede.com. About GemplusGemplus International S.A. (Euronext: LU0121706294 - GEM and NASDAQ: GEMP) isthe world's leading player in the smart card industry in both revenue and totalshipments (source: Gartner-Dataquest (2004), Frost & Sullivan, Datamonitor.). Ithas sold over 4 billion smart cards.With security at its core, and 2400 patents produced by its innovative R&D team,Gemplus delivers a wide range of portable, personalized solutions in areasincluding Identity, Mobile Telecommunications, Public Telephony, Banking,Retail, Transport, Healthcare, WLAN, Pay-TV, e-government, and access control. Gemplus' revenue in 2003 was 749 million Euros. www.gemplus.com ENQUIRIES:Intercede Group plc Tel. 01455 558111Richard Parris Chairman & Chief ExecutiveAndrew Walker Finance Director This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report
26th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.